Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia

Journal of Psychiatric Research

Volumn 36, Issue 5, 2002, Pages 331-336

  Yang Zhang, Xiang ^a,b,c   Feng Zhou, Dong ^a   Yuan Cao, Lian ^b   Yan Zhang, Pei ^b   Ying Wu, Gui ^b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4+cell; Cytokine; Immunology; Interleukin 2; Schizophrenia

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROIMMUNOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SECRETORY CELL; T LYMPHOCYTE; BIOSYNTHESIS; IMMUNOLOGY; MIDDLE AGED; RADIOIMMUNOASSAY;

ADULT; ANTIGENS, CD4; FEMALE; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SCHIZOPHRENIA;

EID: 0036019997     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(02)00023-7     Document Type: Article

References (43)

1. Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses
2. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
3. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients
4. Biological significance of soluble IL-2 receptor
5. Increased levels of CD8+ and CD4+ 45RA lymphocytes in schizophrenic patients
6. Cytokines production in chronic schizophrenia patients with or without paranoid behavior
7. Cytokine profiles in drug-naive schizophrenic patients
8. Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy
9. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
10. Interleukin-6 plasma levels in depression and schizophrenia: comparsion between the acute state and after remission
11. T lymphocytes in schizophrenics and normals and the effects of varying antipsychotic dosage
12. Decreased IL-2 production in schizophrenic patients
13. Altered IL-2 production in schizophrenia: association between clinical state and autoantibody production
14. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients
15. T lymphocyte subpopulations in schizophrenic patients
16. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia
17. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications
18. Decreased interleukin-2 production in Korean schizophrenic patients
19. Relationship between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
20. Cytokines and the brain: implications for clinical psychiatry
21. The inflammatory response system in treatment-resistant schizophrenia: increase serum interleukin-6
22. Smoking and schizophrenia
23. Short and long term immunosuppressive effects of clozapine and haloperidol
24. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stablizers
25. In vivo immunomodulatory effects of clozapine in schizophrenia
26. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics
27. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
28. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy
29. Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients
30. Cytotoxic gamma/delta cells (γδ+ CD 8+) are elevated in unmedicated schizophrenic patients and related to the blood-brain barrier and the HLA allele DPA 02011
31. The role of immune function in schizophrenia: an overview
32. Increased production of interleukin-2 but not soluble interleukine-2 receptors in unmedicated patients with schizophrenia and schizophreniform disorder
33. The immune system is a key factor in the etiology of psychosocial disease
34. A comprehensive macrophage-T-lymphocyte theory of schizophrenia
35. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence
36. Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist
37. T cell subsets in schizophrenia: a comparison between drug-naïve first episode patients and chronic schizophrenic patients
38. Instruction manual for the Structured Clinical Interview for DSM-III-R (SCID). Biometrics Research Division
39. Elevated interleukin-6 in schizophrenia
40. Aberrant T cell-immunity in untreated schizophrenic patients: Deficient interleukin-2 production
41. Investigation of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients
42. Cytokine-specific central monoamine alterations induced by interleukin-1,-2, and-6
43. T-cell subsets in chronic patients with schizophrenia